Wednesday, February 8, 2012
"Concise industry news from the US pharmaceutical industry..."
Sponsors
Platinum Sponsors
Nanopoint, Inc.
is a privately-held biotechnology company that develops and markets unique cellular imaging systems for the life sciences market.
Read More
is a privately-held biotechnology company that develops and markets unique cellular imaging systems for the life sciences market.
Read More
Gold Sponsors
Waters Corp.
For 50 years, Waters has developed innovative analytical science solutions to support customer discoveries, operations, performance, and regulatory compliance.
Read More
For 50 years, Waters has developed innovative analytical science solutions to support customer discoveries, operations, performance, and regulatory compliance.
Read More
Silver Sponsors
Platinum Sponsors
Nanopoint, Inc.
is a privately-held biotechnology company that develops and markets unique cellular imaging systems for the life sciences market.
Read More
is a privately-held biotechnology company that develops and markets unique cellular imaging systems for the life sciences market.
Read More
Gold Sponsors
Waters Corp.
For 50 years, Waters has developed innovative analytical science solutions to support customer discoveries, operations, performance, and regulatory compliance.
Read More
For 50 years, Waters has developed innovative analytical science solutions to support customer discoveries, operations, performance, and regulatory compliance.
Read More
Silver Sponsors
Blog
Spencer Green
Chairman, GDS International
Chairman, GDS International
Sales and the 'Talent Magnet'
A lot is written about being a ‘Talent Magnet’, either as a company, or as President. It’s all good practice – listen, mentor, reward, provide clear goals and career maps. Good practice for the employer, but what about the employee?25 May 2011
White Papers
Focus Area: Insight
1 of 2
Previous |
Next
Insight
Pharma’s Rising Stars
A revenue drain has hit the industry – yet there are still pharma firms blossoming in these arid conditions. An NGP profile.
No Comments
Trouble in the FDA pipeline?
Has the prodigious American drug development machine started to sputter? Peter Pitts,
Director of the Center for Medicine in the Public Interest and a former Associate Commissioner of the FDA, investigates…
No Comments
Gambling on the corporate dollar
Las Vegas is proving a fertile meeting place for the exchange of pharma ideas.
No Comments
In safe hands
A secure e-mail system can save the pharmaceutical industry US$1 million a day.
No Comments
1 of 2
Previous |
Next
Source: www.ngpharma.com© 2012 GDS Publishing Ltd. All rights reserved.